Melanocortin receptor ligands

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S253010, C544S384000, C544S363000

Reexamination Certificate

active

06911447

ABSTRACT:
Disclosed are MC-3/MC-4 receptor ligands, the ligands having the following formula:wherein A is a conformationally restricted ring system selected from the group consisting of:a) non-aromatic carbocyclic rings;b) aromatic carbocyclic rings;c) non-aromatic heterocyclic rings;d) aromatic heterocyclic rings;wherein said rings comprises from 5 to 8 atoms; and W is a unit which preferable comprises D-1-fluorophenyalanine, Y comprises a heteroatom, and Z comprises an aromatic carbocyclic ring. Also disclosed are pharmaceutical compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 receptors.

REFERENCES:
patent: 5492916 (1996-02-01), Morriello et al.
patent: 5494919 (1996-02-01), Morriello et al.
patent: 5536716 (1996-07-01), Chen et al.
patent: 5721250 (1998-02-01), Morriello et al.
patent: 5721251 (1998-02-01), Chen et al.
patent: 5783582 (1998-07-01), Guo et al.
patent: 5804578 (1998-09-01), Chakravarty et al.
patent: 5877182 (1999-03-01), Nargund et al.
patent: 5880125 (1999-03-01), Nargund
patent: 5936089 (1999-08-01), Carpino et al.
patent: 5965565 (1999-10-01), Chen et al.
patent: 6294534 (2001-09-01), Nargund et al.
patent: 6350760 (2002-02-01), Bakshi et al.
patent: WO 94/13696 (1994-06-01), None
patent: WO 94/19367 (1994-09-01), None
patent: WO 96/02530 (1996-02-01), None
patent: WO 96/13265 (1996-05-01), None
patent: WO 96/38471 (1996-12-01), None
patent: WO 98/10653 (1998-03-01), None
patent: WO 99/55679 (1999-11-01), None
patent: WO 99/58501 (1999-11-01), None
patent: WO 99/64002 (1999-12-01), None
patent: WO 00/74679 (2000-12-01), None
patent: WO 01/70337 (2001-09-01), None
patent: WO 01/70708 (2001-09-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 02/00654 (2002-01-01), None
patent: WO 02/15909 (2002-02-01), None
patent: WO 02/59107 (2002-08-01), None
patent: WO 02/59117 (2002-08-01), None
patent: WO 02/68387 (2002-09-01), None
patent: WO 02/68388 (2002-09-01), None
patent: WO 02/70511 (2002-09-01), None
patent: WO 03/031410 (2003-04-01), None
Fisher et al. Melanocortin-4 receptor: a novel signalling pathway involved in body wieght regulation, Int. J. Obes. Relat. Metab. 1999, Suppl 1:54-8 (Abstract).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Melanocortin receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melanocortin receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanocortin receptor ligands will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3488254

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.